European Journal of Medicinal Chemistry p. 29 - 43 (2018)
Update date:2022-08-02
Topics:
OuYang, Yiqiang
Zou, Wensheng
Peng, Liang
Yang, Zunhua
Tang, Qidong
Chen, Mengzi
Jia, Shuang
Zhang, Hong
Lan, Zhou
Zheng, Pengwu
Zhu, Wufu
Eight series of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline were designed, synthesized and evaluated for the IC50 values against three cancer cell lines (A549, MCF-7 and PC-3). Most of the forty nine target compounds showed excellent antiproliferative activity against one or several cancer cell lines. The compound 13a showed the best activity against A549, MCF-7 and PC-3 cancer cell lines, with the IC50 values of 1.09 ± 0.04 μM, 1.34 ± 0.13 μM and 1.23 ± 0.09 μM, respectively. Eight selected compounds were further selected to evaluated for the inhibitory activity against EGFR kinase. Three of them showed equal activity against EGFR kinase to positive control afatinib. AnnexinV-FITC, propidium iodide (PI) double staining and acridine orange single staining results indicated that the compound 13a could induce apoptosis of human lung cancer A549 cells.
View MoreHangzhou Gangjin Chemical Co.,Ltd.(expird)
Contact:+86-571-85109780
Address:707 Zhejiang Minhang Bldg., No.290 Zhongshan North Road, Hangzhou 310003, China
Contact:+86-0592 5353131
Address:No.56 Guani Road Software Park 2,Siming District
Jiangxi Huashi Pharmaceutical Co., Ltd
Contact:+86-795-4509628
Address:Ningbo Ave., Fengtian Industrial Park, Fengxin Country, Jiangxi, China.
ZiBO KuoDing Trade company Ltd
website:http://www.sdzbkd.com
Contact:86-13361591822
Address:GongQingTuan road
Changzhou LanXu Chemical Co.,ltd.(expird)
Contact:86-0519-86330911,13656129734,15261186386
Address:Room 524, Depart.Chemical, Changzhou Science and Eductaion town, Jiangsu, China;Factory: Haian Fine Chemical Industry Park,Nantong,Jiangsu,China
Doi:10.1246/bcsj.49.730
(1976)Doi:10.1021/acs.orglett.0c02465
(2020)Doi:10.1016/j.chemphyslip.2005.07.007
(2005)Doi:10.1016/S0040-4039(00)86229-2
(1983)Doi:10.1016/j.saa.2007.10.006
(2008)Doi:10.1007/s00044-005-0125-z
(2005)